De. Henrich et al., COMPOSITE GRAFT-SURVIVAL - AN AURICULAR AMPUTATION MODEL, Archives of otolaryngology, head & neck surgery, 121(10), 1995, pp. 1137-1142
Objective: To study the effects of corticosteroids and fibroblast grow
th factor on composite graft survival using a rabbit model of auricula
r amputation and reimplantation. Design: Randomized, ''blinded,'' plac
ebo-controlled, prospective animal study.Setting: Animal laboratory in
tertiary care center. Intervention: Amputation of the distal 2 cm of
the rabbit ear as a composite graft and reimplantation with simple 6-0
prolene sutures. All animals underwent the same surgical procedure an
d were randomized into the following four groups: (1) surgical reimpla
ntation alone; (2) 30 mg/kg intramuscular methylprednisolone sodium su
ccinate for 5 days, starting immediately postoperatively; (3) topical
basic fibroblast growth factor for 5 days postoperatively; and (4) del
ayed reimplantation with corticosteroids. In group 4, the ears of the
animal were amputated, placed in iced saline containers for 90 minutes
, and given 30 mg/kg intramuscular methylprednisolone for 5 days, with
the first dose starting immediately prior to reimplantation. Main Out
come Measures: Percentage graft survival and histologic characteristic
s of viable and nonviable composite graft tissue. Results: The groups
that received corticosteroids and delayed reimplantation with corticos
teroids had a statistically significant increase in percentage of graf
t survival compared with the control group (P<.003 and P<.006, respect
ively). The growth factor group showed no significant difference from
the control group. Conclusion: Neovascularization occurred in the viab
le grafts, thus suggesting its role in graft survival. This study esta
blishes the efficacy of corticosteroids in enhancing composite graft s
urvival.